Safety and efficacy of vibostolimab (anti-TIGIT) coformulated with pembrolizumab (vibo/pembro) in previously untreated advanced head and neck squamous cell carcinoma (HNSCC): Results from the phase II KEYVIBE-005 study

---

Toullec C., Seo S., Robinson A. G., Chou H., Salman P., Ghiringhelli F., ...Daha Fazla

ANNALS OF ONCOLOGY, 2024 (SCI-Expanded, Scopus)

• Yayın Türü: Makale / Özet
• Basım Tarihi: 2024
• Doi Numarası: 10.1016/j.annonc.2024.08.917
• Dergi Adı: ANNALS OF ONCOLOGY
• Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, PASCAL, CAB Abstracts, EMBASE, MEDLINE
• Hacettepe Üniversitesi Adresli: Evet